Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author:
Publisher: National Academies
ISBN:
Category : Business & Economics
Languages : en
Pages : 208

Get Book Here

Book Description

Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author:
Publisher: National Academies
ISBN:
Category : Business & Economics
Languages : en
Pages : 208

Get Book Here

Book Description


Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author: United States. Congress. Office of Technology Assessment
Publisher: DIANE Publishing
ISBN: 1428920900
Category : Drugs
Languages : en
Pages : 197

Get Book Here

Book Description


Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author:
Publisher:
ISBN: 9780849090646
Category :
Languages : en
Pages :

Get Book Here

Book Description
Examines the status of drug labeling by 18 U.S.-based multinational pharmaceutical companies in developing countries (Brazil, Kenya, Panama and Thailand). Includes: codes of conduct and voluntary guidelines for pharmaceutical information, efforts to improve drug information in developing countries, drug registration in developing countries, and much more. References, index and illustrations.

Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author: DIANE Publishing Company
Publisher: DIANE Publishing
ISBN: 9780788101090
Category :
Languages : en
Pages : 0

Get Book Here

Book Description
Examines the status of drug labeling by 18 U.S.-based multinational pharmaceutical companies in developing countries (Brazil, Kenya, Panama and Thailand). Includes: codes of conduct and voluntary guidelines for pharmaceutical information, efforts to improve drug information in developing countries, drug registration in developing countries, and much more. References, index and illustrations.

Drug Labeling in Developing Countries

Drug Labeling in Developing Countries PDF Author: United States. Congress. Office of Technology Assessment
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 193

Get Book Here

Book Description


Drug Labeling in Development Countries

Drug Labeling in Development Countries PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Drug Labeling in Developing and Newly-Industrialized Countries

Drug Labeling in Developing and Newly-Industrialized Countries PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 75

Get Book Here

Book Description


Guidelines for Developing National Drug Policies

Guidelines for Developing National Drug Policies PDF Author: World Health Organization
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 60

Get Book Here

Book Description


Bad Medicine

Bad Medicine PDF Author: Milton Silverman
Publisher: Stanford University Press
ISBN: 0804766673
Category : Social Science
Languages : en
Pages : 380

Get Book Here

Book Description
The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups—the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)—all of which were or still are centers of worldwide, heated controversy.

Regulation of Pharmaceuticals in Developing Countries

Regulation of Pharmaceuticals in Developing Countries PDF Author: D. C. Jayasuriya
Publisher: World Health Organization
ISBN: 9789241560894
Category : Law
Languages : en
Pages : 118

Get Book Here

Book Description